A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

Clinical trial NCT06474663 · WITHDRAWN

Trial details

NCT number: NCT06474663
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Acute Leukemia Relapsed Acute Leukemia

Start date: 2025-07-31
Primary completion: 2025-07-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.